Posts Tagged 'low-t'

Androgel Maker Ordered to Pay Up With $150 Million Verdict

Androgel maker loses case for $150 million verdictOne would think that a verdict of this magnitude would send a very loud, very clear message to Androgel maker AbbVie. Unfortunately, the testosterone therapy maker may actually escape paying on this verdict, calling into question whether the company will still “hear” the jury.

The $150 million testosterone verdict was just issued in the case of an Oregon man whose lawsuit accused AbbVie of hiding the risk of ...

continue reading...

Life Time Fitness Sued By In-House Testosterone Clinic Partner

life time fitness sued by low t centerRegardless of the controversies surrounding testosterone therapy and the associated lawsuits, many people assume that there is still, at least, an actual medical condition which warrants some kind of medical treatment with testosterone. A new suit filed against Life Time Fitness, however, may call cause some to rethink that assumption.

In 2014, Life Time Fitness chose a company called Low T Center as its partner to offer testosterone ...

continue reading...

Federal Testosterone Therapy Lawsuits Top 3,000

3000 cases in testosterone therapy lawsuitsAccording to recent data from the U.S. Judicial Panel on Multidistrict Litigation, the number of testosterone therapy lawsuits pending in federal court has climbed to 3,238. The Illinois multidistrict litigation, established in June 2014, initially included just eight testosterone lawsuits.

Popular Low-T drugs like AndroGel, Axiron, and Testim are approved by the U.S. Food and Drug Administration (FDA) for use in men whose testosterone is low due to a medical ...

continue reading...

Endocrinology Groups Echo FDA Call for More Research on Testosterone Therapy Risks

endocrinologist group calls for testosterone therapy researchThe American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) recently issued a joint position statement on the cardiovascular risks of testosterone therapy. In the statement, the two endocrinology groups questioned the FDA’s recommended method for determining whether a patient requires testosterone therapy and call for more research on the health risks posed by Low-T products.

The FDA has indicated that testosterone therapy is approved ...

continue reading...

AbbVie Unhappy with Testosterone MDL Bellwether Trial Selection

abbvie not happy with bellwether trail selectionAbbVie, maker of the popular testosterone therapy product AndroGel, has expressed dissatisfaction with the federal court’s bellwether trial selection process, Forbes reports. The U.S. District Court for the Northern District of Illinois has chosen AbbVie to defend in the first MDL testosterone lawsuit to go to trial. AbbVie, a defendant in the fast-growing Illinois testosterone therapy MDL, has been instructed to select 32 potential cases to be prepared for bellwether ...

continue reading...

Testosterone Therapy Lawsuits Not Letting Up as South Carolina Claim Joins MDL

more testosterone therapy lawsuits join multidistrict litigationThe most recent report from the U.S. Judicial Panel on Multidistrict Litigation shows 2,231 testosterone lawsuits included in the Illinois MDL —and there’s no sign that the flood of lawsuits will let up any time soon. According to the Public Access to Court Electronic Records (PACER) database, over 40 new testosterone lawsuits were filed in the last week alone. A testosterone lawsuit filed last month by a South Carolina couple ...

continue reading...
Page 1 of 3 123